NCT07415798

Brief Summary

This is a single-center, non-interventional, observational, cross-sectional clinical study designed to quantitatively and qualitatively characterize skin properties in a cohort of 100 Chinese female Subjects aged 20 to 70 years. The study involves no product application and poses minimal risk to participants. The primary objectives are to establish a comprehensive skin aging profile database, characterize skin color, aging signs, and biomechanical properties, and create a histomorphometric database for the development and validation of ordinal photographic scales for aging research. Data will be collected through questionnaires, clinical assessments (including LC-OCT imaging), standardized photography, and non-invasive biophysical measurements. All procedures will be conducted in accordance with the ethical principles originating from the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and the relevant laws and regulations of China (including the \*Measures for the Ethical Review of Biomedical Research Involving Human Subjects\*). All data will be anonymized and stored securely.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
7mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jan 2026Jan 2027

Study Start

First participant enrolled

January 15, 2026

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 10, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2027

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

12 months

First QC Date

February 10, 2026

Last Update Submit

February 10, 2026

Conditions

Outcome Measures

Primary Outcomes (8)

  • Epidermal Thickness

    Single visit, day 1

  • Dermal-Epidermal Junction (DEJ) Undulation Index

    Single visit, day 1

  • Mean Dermal Reflectivity

    Single visit, day 1

  • Stratum Corneum Thickness

    Single visit, day 1

  • Correlation between LC-OCT parameters and chronological age

    Single visit, day 1

  • Skin colorimetric parameter L*a*b*

    Single visit, day 1

  • Correlation between LC-OCT parameters and clinician-graded scores

    Single visit, day 1

  • Correlation between LC-OCT parameters and questionnaire factors

    Single visit, day 1

Secondary Outcomes (3)

  • Clinician-graded score of skin texture/pores

    Single visit, day 1

  • Clinician-graded score of skin pigmentation

    Single visit, day 1

  • Clinician-graded score of facial wrinkles

    Single visit, day 1

Study Arms (5)

Group 20 to 29 Years old

Group 30 to 39 Years old

Group 40 to 49 Years old

Group 50 to 59 Years old

Group 60 to 69 Years old

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Approximately 100 healthy Chinese female Subjects, evenly distributed across age groups (20-29, 30-39, 40-49, 50-59, 60-70 years).

You may qualify if:

  • Chinese female, aged between 20 and 70 years (inclusive) at the time of signing consent.
  • Willing and able to provide written informed consent.
  • Fitzpatrick Skin Phototype II or III.
  • Willing to comply with all study procedures, including removal of facial makeup and avoidance of intensive skincare (e.g., retinoids, strong acids) on the test areas for 3 days prior to the visit as per instructions.

You may not qualify if:

  • Pregnant, planning pregnancy, or breastfeeding (as hormonal changes significantly affect skin properties).
  • Presence of temporary tanning, sunburn, or significant erythema on the face or measurement areas.
  • Presence of facial piercings, tattoos, too much fluff or significant scarring that would interfere with imaging or measurements in the areas of interest.
  • History of any aesthetic or surgical procedure on the face (e.g., laser therapy, chemical peels, injectable fillers, botulinum toxin, plastic surgery) within the past 12 months.
  • Current diagnosis or visible signs of a skin disease (e.g., psoriasis, eczema, active acne, rosacea) or a systemic disease known to affect the skin (e.g., diabetes, lupus) on the face or measurement areas.
  • Use of systemic medications known to affect skin physiology (e.g., oral retinoids, immunosuppressants, long-term corticosteroids) within the past 3 months, or for a cumulative duration of ≥6 months within the past 2 years.
  • Participation in another clinical study on the face or arms within the past 1 month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HKRI Centre One

Shanghai, Shanghai Municipality, 200072, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2026

First Posted

February 17, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 15, 2027

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations